2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by VAN LIEBURG, A. F. Articles by MONNENS, L. A. H. Search for Related Content PubMed PubMed Citation Articles by VAN LIEBURG, A. F. Articles by MONNENS, L. A. H.

Clinical Presentation and Follow-Up of 30 Patients with Congenital Nephrogenic Diabetes Insipidus

ANGENITA F. VAN LIEBURG^*, NINE V. A. M. KNOERS and LEO A. H. MONNENS^*

^* Department of Pediatrics University Hospital Nijmegen, The Netherlands.
Department of Human Genetics, University Hospital Nijmegen, The Netherlands.

Correspondence to Dr. Angenita F. van Lieburg, Department of Pediatrics, University Hospital Nijmegen, P. O. Box 9101, 6500 HB Nijmegen, The Netherlands. Phone: 31 24 3616872; Fax: 31 24 3616428; E-mail: F.verhoeven{at}mailbox.kun.nl

Abstract

Abstract. Congenital nephrogenic diabetes insipidus is characterized by insensitivity of the distal nephron to arginine vasopressin. Clinical knowledge of this disease is based largely on case reports. For this study, data were collected on clinical presentation and during long-term follow-up of 30 male patients with congenital nephrogenic diabetes insipidus. The majority of patients (87%) were diagnosed within the first 2.5 yr of life. Main symptoms at clinical presentation were vomiting and anorexia, failure to thrive, fever, and constipation. Three older patients were diagnosed as a result of events not directly related to the disease. Except for a possibly milder phenotype in patients with a G185C mutation, no clear relationship between clinical and genetic data could be found. Most patients were on hydrochlorothiazide-amiloride treatment without significant side effects. Two patients suffered from severe hydronephrosis with a small rupture of the urinary tract after a minor trauma, and two patients experienced episodes of acute urine retention. Height SD scores for age remained below the 50th percentile in the majority of patients, whereas weight for height SD scores showed a catch-up after several years of underweight.

This article has been cited by other articles:

				A. P. Sharma, R. K. Sharma, R. Kapoor, A. Kornecki, S. Sural, and G. Filler Incomplete distal renal tubular acidosis affects growth in children Nephrol. Dial. Transplant., October 1, 2007; 22(10): 2879 - 2885. [Abstract] [Full Text] [PDF]

				M L Marcovecchio An infant with chronic hypernatremia Eur. J. Endocrinol., November 1, 2006; 155(suppl_1): S141 - S144. [Abstract] [Full Text] [PDF]

				J. H. Robben, N. V. A. M. Knoers, and P. M. T. Deen Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus. Am J Physiol Renal Physiol, August 1, 2006; 291(2): F257 - F270. [Abstract] [Full Text] [PDF]

				J. M. Sands and D. G. Bichet Nephrogenic Diabetes Insipidus Ann Intern Med, February 7, 2006; 144(3): 186 - 194. [Full Text] [PDF]

				V. Bernier, J.-P. Morello, A. Zarruk, N. Debrand, A. Salahpour, M. Lonergan, M.-F. Arthus, A. Laperriere, R. Brouard, M. Bouvier, et al. Pharmacologic Chaperones as a Potential Treatment for X-Linked Nephrogenic Diabetes Insipidus J. Am. Soc. Nephrol., January 1, 2006; 17(1): 232 - 243. [Abstract] [Full Text] [PDF]

				S. Sasaki Nephrogenic diabetes insipidus: update of genetic and clinical aspects Nephrol. Dial. Transplant., June 1, 2004; 19(6): 1351 - 1353. [Full Text] [PDF]

				M. A.J. Devonald and F. E. Karet Renal Epithelial Traffic Jams and One-Way Streets J. Am. Soc. Nephrol., June 1, 2004; 15(6): 1370 - 1381. [Full Text] [PDF]

				H. Shalev, I. Romanovsky, N. V. Knoers, S. Lupa, and D. Landau Bladder function impairment in aquaporin-2 defective nephrogenic diabetes insipidus Nephrol. Dial. Transplant., March 1, 2004; 19(3): 608 - 613. [Abstract] [Full Text] [PDF]

				K. Hirano, C. Zuber, J. Roth, and M. Ziak The Proteasome Is Involved in the Degradation of Different Aquaporin-2 Mutants Causing Nephrogenic Diabetes Insipidus Am. J. Pathol., July 1, 2003; 163(1): 111 - 120. [Abstract] [Full Text] [PDF]

				N. Marr, D. G Bichet, M. Lonergan, M.-F. Arthus, N. Jeck, H. W. Seyberth, W. Rosenthal, C. H. van Os, A. Oksche, and P. M. T. Deen Heteroligomerization of an Aquaporin-2 mutant with wild-type Aquaporin-2 and their misrouting to late endosomes/lysosomes explains dominant nephrogenic diabetes insipidus Hum. Mol. Genet., April 1, 2002; 11(7): 779 - 789. [Abstract] [Full Text] [PDF]

				M. Nijenhuis, E. L. T. van den Akker, R. Zalm, A. A. M. Franken, A. P. Abbes, H. Engel, D. de Wied, and J. P. H. Burbach Familial Neurohypophysial Diabetes Insipidus in a Large Dutch Kindred: Effect of the Onset of Diabetes on Growth in Children and Cell Biological Defects of the Mutant Vasopressin Prohormone J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3410 - 3420. [Abstract] [Full Text] [PDF]

				M.-F. ARTHUS, M. LONERGAN, M. J. CRUMLEY, A. K. NAUMOVA, D. MORIN, L. A. DE MARCO, B. S. KAPLAN, G. L. ROBERTSON, S. SASAKI, K. MORGAN, et al. Report of 33 Novel AVPR2 Mutations and Analysis of 117 Families with X-Linked Nephrogenic Diabetes Insipidus J. Am. Soc. Nephrol., June 1, 2000; 11(6): 1044 - 1054. [Abstract] [Full Text]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673